KR910004190A - 온단세트론의 신규 의학 용도 - Google Patents
온단세트론의 신규 의학 용도 Download PDFInfo
- Publication number
- KR910004190A KR910004190A KR1019900011701A KR900011701A KR910004190A KR 910004190 A KR910004190 A KR 910004190A KR 1019900011701 A KR1019900011701 A KR 1019900011701A KR 900011701 A KR900011701 A KR 900011701A KR 910004190 A KR910004190 A KR 910004190A
- Authority
- KR
- South Korea
- Prior art keywords
- therapeutic agent
- ondansetron
- agent according
- administration
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (6)
- 온단세트론 또는 그의 생리학적으로 허용되는 염 또는 용매화물을 활성 성분으로 하는, 식욕 항진 또는 그와 관련된 질병 치료용 치료제.
- 제1항에 있어서, 경구 투여, 구강 투여, 비경구 투여, 직장 투여, 경피 투여용으로 적합한 형태이거나 또는 흡입 또는 취입에 의한 투여용으로 적합한 형태인 것이 특징인 치료제.
- 제1항 또는 제2항 중 어느 한 항에 있어서, 단위 용량 당 활성성분을 유리 염기 중량으로 환산하여 0.05 내지 20㎎함유하는 단위 용량형인 것이 특징인 치료제.
- 제3항에 있어서, 단위 용량 당 활성 성분 0.1 내지 10㎎을 함유하는 것이 특징인 치료제.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 온단세트론이 염산염의 형태로 사용되는 것이 특징인 치료제.
- 제5항에 있어서, 활성 성분이 온단세트론 염산염 이수화물인 것이 특징인 치료제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB89175566 | 1989-08-01 | ||
GB898917556A GB8917556D0 (en) | 1989-08-01 | 1989-08-01 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
KR910004190A true KR910004190A (ko) | 1991-03-28 |
Family
ID=10660972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900011701A KR910004190A (ko) | 1989-08-01 | 1990-07-31 | 온단세트론의 신규 의학 용도 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0411900A3 (ko) |
JP (1) | JPH03218311A (ko) |
KR (1) | KR910004190A (ko) |
CA (1) | CA2022379A1 (ko) |
GB (1) | GB8917556D0 (ko) |
IE (1) | IE902769A1 (ko) |
IL (1) | IL95245A (ko) |
ZA (1) | ZA905997B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
EP0591434A4 (en) * | 1991-06-26 | 1994-09-14 | Sepracor Inc | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
GB9423511D0 (en) * | 1994-11-22 | 1995-01-11 | Glaxo Wellcome Inc | Compositions |
AU779696B2 (en) | 1999-03-01 | 2005-02-10 | Sepracor, Inc. | Methods for treating apnea and apnea disorders using optically pure R(+)ondansetron |
CN104274395A (zh) * | 2014-09-19 | 2015-01-14 | 威海爱威制药有限公司 | 盐酸昂丹司琼氯化钠注射液及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
-
1989
- 1989-08-01 GB GB898917556A patent/GB8917556D0/en active Pending
-
1990
- 1990-07-31 ZA ZA905997A patent/ZA905997B/xx unknown
- 1990-07-31 IE IE276990A patent/IE902769A1/en unknown
- 1990-07-31 KR KR1019900011701A patent/KR910004190A/ko not_active Application Discontinuation
- 1990-07-31 CA CA002022379A patent/CA2022379A1/en not_active Abandoned
- 1990-07-31 EP EP19900308412 patent/EP0411900A3/en not_active Ceased
- 1990-07-31 JP JP2203757A patent/JPH03218311A/ja active Pending
- 1990-07-31 IL IL9524590A patent/IL95245A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2022379A1 (en) | 1991-02-02 |
IL95245A (en) | 1995-03-15 |
ZA905997B (en) | 1991-06-26 |
IE902769A1 (en) | 1991-02-27 |
JPH03218311A (ja) | 1991-09-25 |
EP0411900A2 (en) | 1991-02-06 |
GB8917556D0 (en) | 1989-09-13 |
EP0411900A3 (en) | 1992-09-09 |
IL95245A0 (en) | 1991-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880007073A (ko) | 의 약 품 | |
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
BR0116607A (pt) | Derivados de glicopiranosiloxipirazol e uso dos mesmos em medicamentos | |
KR900701282A (ko) | 심장 또는 뇌의 허혈성 질환의 치료, 예방제 | |
GEP20043324B (en) | Purine Derivatives | |
KR950016744A (ko) | 트롬빈을 저해하는 방법 | |
DK0724885T3 (da) | Pernasal sammensætning og pernasalt præparat indeholdende dette | |
SE9901573D0 (sv) | New compounds | |
KR880007074A (ko) | 의약품 | |
KR970025615A (ko) | 암 전이 억제제 | |
AR019053A1 (es) | Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen | |
BR9917112A (pt) | Compostos de imidazol e seu uso medicinal | |
ES2062610T3 (es) | Compuesto diarilico anti-ateroesclerotico. | |
KR880007079A (ko) | 레트로비루스에 감염된 환자치료에 있어서의 3'-디옥시티미딘-2'-엔(3'-디옥시-2',3'-디디하이드로티미딘)의 사용법 | |
DE69322251D1 (de) | Medizinische zusammensetzung | |
KR880005930A (ko) | 탐닉 치료용 의약품 | |
KR880007060A (ko) | 제약 조성물 | |
FR2680172B1 (fr) | Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique. | |
LV10267A (lv) | Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai | |
KR910004190A (ko) | 온단세트론의 신규 의학 용도 | |
KR920019350A (ko) | 자기면역질환요법을 위한 약제조성물 | |
SE9901572D0 (sv) | New compounds | |
OA07029A (fr) | Le chlorure de gallium, nouveau médicament anti-cancéreux. | |
IT1241079B (it) | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico | |
KR890004705A (ko) | 항바이러스성 제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |